Ferlin Family

Ferlin 蛋白家族由包含 C2 结构域的蛋白组成,这些蛋白在囊泡融合和膜转运中起着关键作用。哺乳动物中含有六个 Ferlin 蛋白 (Fer1L1-6),分别为 Dysferlin (DYSF), Otoferlin (OTOF), Myoferlin (MYOF), Fer1L4 (Ferlin 4), Fer1L5 (Ferlin 5), Fer1L6 (Ferlin 6)。根据是否含有 DysF 和 FerA 结构域分为两类:Class I (含 DysF 和 FerA) 和 Class II (不含 DysF 和 FerA)。
Ferlin 蛋白通过与细胞骨架运动蛋白、其他囊泡相关的转运蛋白和跨膜受体或通道的相互作用,参与细胞内的囊泡转运和膜修复过程,并在钙信号的调控下调节细胞内的囊泡融合,影响神经传递和受体的再循环。这些蛋白与多种信号通路相关,包括细胞内的钙调节机制和囊泡的动态平衡。例如,Dysferlin 与钙激活的膜修复直接相关,而 Otoferlin 在听觉传递中对于神经递质囊泡的钙激活释放至关重要。Ferlin 蛋白功能异常会导致肌肉营养不良和耳聋等疾病。如,Dysferlin 的缺陷会导致一种渐进性的肌肉营养不良,而 Otoferlin 的缺陷则与非综合征型耳聋有关[1]。

The Ferlin protein family consists of proteins containing C2 domains, which play a key role in vesicle fusion and membrane transport. Mammals have six Ferlin proteins (Fer1L1-6), namely Dysferlin (DYSF), Otoferlin (OTOF), Myoferlin (MYOF), Fer1L4 (Ferlin 4), Fer1L5 (Ferlin 5), and Fer1L6 (Ferlin 6). These are classified into two categories based on the presence or absence of the DysF and FerA domains: Class I (containing DysF and FerA) and Class II (lacking DysF and FerA).
Ferlin proteins participate in intracellular vesicle transport and membrane repair processes through interactions with cytoskeletal motor proteins, other vesicle-related transport proteins, and transmembrane receptors or channels. They regulate vesicle fusion under the control of calcium signaling, affecting neurotransmission and receptor recycling. These proteins are associated with various signaling pathways, including intracellular calcium regulation and vesicle dynamics. For example, Dysferlin is directly involved in calcium-activated membrane repair, while Otoferlin is crucial for calcium-activated release of neurotransmitter vesicles in auditory transmission. Dysfunction of Ferlin proteins can lead to diseases such as muscular dystrophy and hearing loss. For instance, defects in Dysferlin cause progressive muscular dystrophy, while defects in Otoferlin are associated with non-syndromic hearing loss[1].

By Effects: Inhibitor (1)
共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
HJ445A

HJ445A 是一种具有口服活性的肌铁蛋白 (MYOF) 抑制剂,针对人源靶点的 Kd 值为 0.17 μM,可直接结合 MYOF-C2D 结构域稳定 MYOF 蛋白,从而调控癌细胞的囊泡运输、细胞增殖、集落形成、迁移及凋亡 (apoptosis) 过程并展现抗肿瘤功效,可用于胃癌相关研究。

3032441-59-8
Inhibitor
98.02%
HJ445A

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础